Himanshu Banda, MD
Retina Specialist · Tacoma, WANPI 1205179496
Payments from drug & device makers
Across 139 payments — averaging $695.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Apellis Pharmaceuticals, Inc.$82K
- Dutch Ophthalmic, USA$3K
- Genentech USA, Inc.$3K
- Genentech, Inc.$2K
- Carl Zeiss Meditec USA, Inc.$2K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $4K from 14 others
Across 41 payments — averaging $42.44 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Apellis Pharmaceuticals, Inc. | 4 | $81,640 |
| Dutch Ophthalmic, USA | 20 | $3,291 |
| Genentech USA, Inc. | 8 | $2,535 |
| Genentech, Inc. | 8 | $2,260 |
| Carl Zeiss Meditec USA, Inc. | 1 | $2,120 |
| Regeneron Healthcare Solutions, Inc. | 23 | $1,324 |
| Harrow Eye, LLC | 7 | $824 |
| AbbVie(2 entities) | 27 | $786 |
| Alimera Sciences, Inc. | 13 | $672 |
| Eyepoint US, Inc. | 9 | $373 |
| Bausch & Lomb Americas Inc. | 3 | $183 |
| Alcon | 3 | $164 |
| Dexcom, Inc. | 1 | $111 |
| Novartis | 1 | $106 |
| Amgen | 2 | $96 |
| Astellas Pharma US Inc | 3 | $69 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $58 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| ASD Specialty Healthcare, LLC | 1 | $28 |
| Biogen | 1 | $23 |
How this compares
Too few retina specialist providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Tacoma
- George KoRenton$28K
- Evelyn FuPuyallup$22K
- Rahul MandigaAuburn$17K
- Peter ClarkWenatchee$7K
- Minh TrinhAuburn$4K
- Benjamin ReissAuburn$4K
- Michael GilbertBellevue$3K
- David DruckerSeattle$1K
- Brenda Myers PowellFederal Way$422
- Kinza AhmadEverett$363
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.